1 citations
,
January 2024 in “Nature communications” Activating TLR5 in the gut can extend lifespan and improve health in aged mice.
1 citations
,
November 2023 in “Journal of the European Academy of Dermatology and Venereology” Baricitinib helps with early hair regrowth in people with alopecia areata.
1 citations
,
March 2023 in “bioRxiv (Cold Spring Harbor Laboratory)” NAC1 controls certain enzymes that reduce root hair growth in Arabidopsis.
1 citations
,
January 2023 in “Frontiers in Physiology” The method allows precise cell removal without harming nearby tissues.
1 citations
,
October 2021 in “PubMed” A woman had temporary hair loss after scalp surgery, which is a rare but self-healing condition that surgeons should recognize to avoid wrong treatment.
1 citations
,
April 2021 in “The journal of investigative dermatology/Journal of investigative dermatology” mTORC1 activity is important for hair growth and color, and targeting it could help treat hair loss and greying.
1 citations
,
April 2021 in “Journal of Cosmetic Dermatology” The cream effectively reduced hair growth on forearms.
1 citations
,
November 2019 in “Dermatologic Therapy” June 2026 in “EJC Paediatric Oncology” High-dose thiotepa and twice-daily treatments increase the risk of permanent hair loss in children receiving craniospinal irradiation.
April 2026 in “Clinical and Experimental Dermatology” Dupilumab effectively reduces symptoms of prurigo nodularis and is safe for long-term use.
April 2026 in “Italian Journal of Dermatology and Venereology” March 2026 in “International Journal of Dermatology” Topical finasteride effectively and safely improves hair growth in men with androgenetic alopecia.
February 2026 in “Clinical Drug Investigation” Baricitinib significantly improves nail and hair symptoms in severe alopecia areata.
January 2026 in “JAAD International” Baricitinib effectively promotes beard regrowth in most men with alopecia areata universalis.
January 2026 in “Advances in Dermatology and Allergology” Stress significantly affects the quality of life in patients with lichen planopilaris and frontal fibrosing alopecia.
October 2025 in “Journal of the European Academy of Dermatology and Venereology” People often have negative attitudes towards facial skin conditions, with vitiligo seen most positively and psoriasis viewed most negatively.
October 2025 in “Pharmaceuticals” Auranofin shows promise as a cancer treatment, especially when combined with other therapies.
September 2025 in “Journal of the European Academy of Dermatology and Venereology” Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.
September 2025 in “Acta Dermato Venereologica” Baricitinib can help improve hair loss and skin color issues in people with Down syndrome.
September 2025 in “Dermatology and Therapy” The treatment improved hair growth and was well-received without side effects.
CRISPR gene editing reduces harmful molecules in cells from Emery–Dreifuss Muscular Dystrophy patients.
Allopregnanolone may help reduce inflammation and symptoms related to post-finasteride syndrome.
Magnetized saline water hydrogel helps heal pressure ulcers quickly in elderly patients.
PCOS may be linked to spina bifida in young females.
June 2025 in “Italian Journal of Dermatology and Venereology” Thorough scalp examination is crucial for diagnosing alopecia areata incognita in men with diffuse hair loss.
April 2025 in “Dermatology Practical & Conceptual” Biopsy is crucial to accurately distinguish Erosive Pustular Dermatosis of the Scalp from Squamous Cell Carcinoma.
April 2025 in “Dermatology Practical & Conceptual” Biopsy is crucial for accurately diagnosing EPDS to avoid mistaking it for SCC.
April 2025 in “Nutrients” Consult an oncologist before using supplements for hair loss during breast cancer treatment.
February 2025 in “Journal of Investigative Dermatology” The ZIP13 variant is linked to abnormal hair quality.
February 2025 in “Journal of the European Academy of Dermatology and Venereology” Erosive pustular dermatosis of the scalp can occur about 17 weeks after starting EGFR inhibitors, and early minocycline may help manage it.